Nanomedicines leading the way Nanotechnology offers multiple benefits in treating chronic diseases by site-specific, and target-oriented delivery of medicines. Nanodelivery systems utilized in drug development are very much still relatively new commercial approach....
Improving patient adherence of oral drug products remains a key challenge for drug manufacturers alike. Check out this article and discussion between Pharmaceutical Technology and Adare Pharmaceuticals which discusses a unique approach for industry. Would you like...
Improving the solubility of poorly soluble APIs remains one of the biggest challenges for pharmaceutical companies. Not to mention the lengthy and costly drug approval processes, generic incursion, rising development costs and the need for novel adherence strategies,...
Enhancing Drug Bioavailability and Solubility Approximately 40% of drugs on the market place and a high percentage of APIs in development are poorly soluble. Optimization of drug solubility and BA of therapeutics stands as one of the top challenges faced by the...
Extended Duration Parenteral Products as Patient Adherence Strategies For a number of years, extended-release parenteral formulations have garnered enormous attention due to their effective drug concentrations over extended periods and improve patient compliance...
Recent Comments